• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Flu vaccine not associated with adverse pregnancy outcomes

bys25qthea
August 10, 2013
in Chronic Disease, Infectious Disease, Obstetrics, Public Health
Reading Time: 3 mins read
Flu vaccine not associated with adverse pregnancy outcomes
Share on FacebookShare on Twitter

Image: PD 

1. In a large cohort study, trivalent inactivated influenza vaccination during pregnancy was not associated with adverse obstetric events. 

2. Women who were vaccinated against influenza during pregnancy were found to have a significantly lower incidence of gestational diabetes compared with controls, which might represent a manifestation of significant baseline differences between exposure groups. 

Evidence Rating Level: 2 (Good)            

Study Rundown: This retrospective cohort study identified no association between the trivalent inactivated influenza vaccine and adverse obstetric outcomes. Women who received the vaccine had a slightly (insignificantly) higher incidence of chorioamnionitis and a significantly lower incidence of gestational diabetes compared with those who did not. These results add to the growing body of evidence that supports the safety of influenza vaccination in pregnancy.

The strength of this study is a large sample size and multi-site cohort design. One limitation of this study is significant differences existed between the two study groups such as preexisting comorbidities and complications, though attempts were made to control for poverty and access to care. For instance, the association between gestational diabetes and influenza vaccination is more likely to represent a baseline differences in cases and controls than a biologically plausible, causal association. Future studies might employ a prospective design and control for confounders to further characterize adverse outcomes, including the associations identified in this investigation.

RELATED REPORTS

First messenger RNA influenza vaccine outperforms standard-dose vaccination

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

Click to read the study in Obstetrics & Gynecology

Relevant Reading: Uptodate: Influenza and pregnancy

Study Author, Dr. Elyse Olshen Kharbanda, MD, MPH, talks to 2 Minute Medicine: Health Partners Institute for Education and Research, Minneapolis, MN

“Our study demonstrates in a large, diverse cohort, that receipt of influenza vaccine during pregnancy was not associated with increased risk for a wide range of adverse obstetric events.  This study should reassure pregnant women and providers that it is safe to receive influenza vaccine during pregnancy.   In future work our team will evaluate potential risks associated with vaccination and preterm delivery, low birth weight and birth defects.

In-Depth [retrospective cohort study]: This retrospective cohort study included pregnant women over a seven year period from seven Vaccine Safety Datalink sites across the U.S. Women who received the trivalent inactivated influenza vaccines during pregnancy (n=74,2929) were identified and matched on age, site, and pregnancy start date in a ratio of one-to-two to unvaccinated pregnant females (n=144,597). Risk of 13 different adverse obstetric events was assessed. Models were adjusted for receipt of first trimester medical care, hospitalization before vaccination, poverty, and other outcome specific factors and given the multiple comparisons, a p-value of <0.005 was considered significant.

There was no difference in the incidence of hyperemesis, chronic hypertension, gestational hypertension, proteinuria, or UTI within 42 days of vaccination. Throughout pregnancy and delivery, vaccination was not associated with a significant increased incidence of proteinuria, UTI, gestational hypertension, preeclampsia/ eclampsia, puerperal infection, venous complications, pulmonary embolism, or peripartum cardiomyopathy. Vaccination was associated with reduced incidence of gestational diabetes (aHR=0.88, p<.001).

By Maren Shapiro and Leah Hawkins, MD, MPH

More from this author: IUD contraception equally safe in teenagers as in older women, Black men less likely to receive follow-up for elevated prostate cancer marker, PSA, Intake of fish fatty acids associated with lower risk of breast cancer, USPSTF recommends chemoprevention for women at high risk for breast cancer, Insurance status affects treatment of early stage breast cancer, SERMs decrease breast cancer risk even after treatment

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: flueimmunizationinfluenzapregnancyvaccine
Previous Post

NEXUS Chest decision criteria sensitive for thoracic injury

Next Post

Promising liver transplant outcomes at 20 years

RelatedReports

Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Social networks play key roles in parental vaccination decisions
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Live attenuated vaccine less effective in recent influenza season
Emergency

Adjuvanted influenza vaccines and high-dose influenza vaccines may have similar effectiveness in adult patients

May 15, 2026
Next Post
Mortality risk higher in pediatric trauma patients with chronic conditions

Promising liver transplant outcomes at 20 years

C-section surgical techniques yield equivalent outcomes

Viagra provides pain relief in primary dysmenorrhea

2 Minute Medicine Rewind: May 13 – May 19

2 Minute Medicine Rewind August 4- August 11, 2013

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.